Article info
PDFUterine Cancer
Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use
- Address correspondence and reprint requests to Kassondra S. Grzankowski, MD, Department of Gynecologic Oncology, Roswell Park Cancer Institute, Elm and Carlton St, Buffalo, NY 14263. E-mail: KassondraG{at}gmail.com.
Citation
Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use
Publication history
- Received February 1, 2016
- Accepted May 21, 2016
- First published October 1, 2016.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.